Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations

Clinical trial NCT06673290 · RECRUITING

Trial details

NCT number: NCT06673290
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lymphatic Malformation

Start date: 2024-11-30
Primary completion: 2026-12-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.